
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
WCG announced its acquisition of
Dave Young, Trifecta’s Founder and CEO, said, “We’re thrilled to be joining WCG, a company that shares our passion for improving the clinical trial process by delivering impactful solutions to age-old problems. This acquisition was a natural evolution for Trifecta.”
Moving forward, Trifecta will be known as WCG Trifecta, and will retain its leadership structure, along with its headquarters in Los Angeles, and locations in Indianapolis, Philadelphia, and Osaka, Japan.
For the full release, click






